Showing results (31-40 of 57) with videos related to
Sort By:
Pageof 6
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 23, 2008
Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimenBungo Saito, Takahiro Fukuda, Hiroki Yokoyama, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 11, 2018
[Transplantation-associated thrombotic microangiopathy confirmed by renal biopsy]Satoshi Miyamoto, Shunsuke Kimura, Yosuke Hosoya, et al.Cancer Science|January 31, 2006
Use of hydroxy-methyl-glutaryl coenzyme A reductase inhibitors is associated with risk of lymphoid malignanciesHiroshi Iwata, Keitaro Matsuo, Shigeo Hara, et al.International Journal of Hematology|August 4, 2010
Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia: a single-center analysis of 47 patientsHiroki Yokoyama, Shin-ichiro Mori, Yukio Kobayashi, et al.American Journal of Hematology|July 26, 2006
Nutritional support for patients suffering from intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantationOsamu Imataki, Shigetoshi Nakatani, Terumi Hasegawa, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 21, 2004
Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen compared with transplantation with a conventional regimenRie Kojima, Masahiro Kami, Yasuhito Nannya, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 21, 2007
Comparable antileukemia/lymphoma effects in nonremission patients undergoing allogeneic hematopoietic cell transplantation with a conventional cytoreductive or reduced-intensity regimenDai Maruyama, Takahiro Fukuda, Ruri Kato, et al.British Journal of Haematology|March 30, 2007
Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor ProgramShinichi Ozawa, Chiaki Nakaseko, Miki Nishimura, et al.Transplantation|November 7, 2007
Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantationShigeo Fuji, Sung-Won Kim, Shin-ichiro Mori, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 3, 2014
Impact of HLA mismatch direction on the outcome of unrelated bone marrow transplantation: a retrospective analysis from the Japan Society for Hematopoietic Cell TransplantationJunya Kanda, Tatsuo Ichinohe, Shigeo Fuji, et al.Pageof 6